Rtw Investments, LP Rocket Pharmaceuticals, Inc. Transaction History
Rtw Investments, LP
- $6.1 Billion
- Q1 2025
A detailed history of Rtw Investments, LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 17,687,772 shares of RCKT stock, worth $53.8 Million. This represents 1.93% of its overall portfolio holdings.
Number of Shares
17,687,772
Previous 17,687,772
-0.0%
Holding current value
$53.8 Million
Previous $222 Million
46.94%
% of portfolio
1.93%
Previous 3.63%
Shares
9 transactions
Others Institutions Holding RCKT
# of Institutions
251Shares Held
107MCall Options Held
558KPut Options Held
177K-
Wellington Management Group LLP Boston, MA12.6MShares$38.4 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.62MShares$20.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$18.8 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$15.8 Million0.68% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.82MShares$14.7 Million0.17% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $230M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...